Drug / electricity synergistic antibacterial and healing promoting suture line and preparation method thereof

The skin core structural fibers were prepared by coaxial wet spinning, and the electrochemical reaction was achieved in the suture using micro/nanocouples, which solved the problem of insufficient antibacterial effect of existing sutures and insufficient strength, and achieved high-quality sutures Line repair and antibacterial effects.

CN118949108APending Publication Date: 2024-11-15QINGDAO UNIV +1

Patent Information

Application Number
CN202411063719.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The antibacterial coating of existing sutures is distributed on the surface of the material, the bonding fastness is poor, it is easy to fall off, and it relies on passive release, the effect is not long-lasting, and the high-temperature melt spinning technology is not suitable for the use of thermally sensitive antibacterial agents, and the preparation of pure nanofibers is complicated. And the intensity is low and cannot meet the actual needs.

Method used

The fibers of the core structure are constructed by coaxial wet spinning, and the micro/nanocouple is used to generate electrochemical reactions in a humid environment to form a closed loop, promote the controlled release of the core layer drug, and regulate the type, content and thickness of the electrodes to Achieve antibacterial, anti-inflammatory and antioxidant effects.

Benefits of technology

It has achieved high-quality repair of sutures, with an antibacterial rate of 96.3%-99.5%, controllable drug release, long duration of electrical stimulation, suitable for large-scale production, and mechanical properties meet the requirements of use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949108A_ABST
    Figure CN118949108A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical materials, in particular to a medicine / electricity synergistic antibacterial and healing promoting suture line and a preparation method thereof, coaxial wet spinning is performed, fibers with skin-core structures are constructed, micro / nano galvanic couples are constructed between skin layers and core layers of the fibers, and the radial water absorption effect is achieved by utilizing the concentration gradient of the skin layers and the core layers in a humid wound environment. The positive electrode and the negative electrode of the micro / nano galvanic couple utilize human tissue seepage as an electrolyte solution to form a closed loop, a primary battery is formed, a discharge reaction and electrochemical corrosion are carried out, so that a cortex is sunken, micropores are further formed, the radial adsorption effect is enhanced, and drug release is promoted. The electrochemical reaction of the micro / nano galvanic couple is controlled to generate electrical stimulation, controllable release of antibacterial, anti-inflammatory and anti-oxidation functional drugs loaded on the core layer is realized by regulating and controlling the type of the electrode pair / galvanic couple pair, the content of the electrode pair / galvanic couple pair, the particle size of the electrode pair / galvanic couple and the thickness of the core / skin layer, and high-quality repair of a sutured wound is promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical materials, in particular to a drug / electricity synergistic antibacterial and healing-promoting suture thread and a preparation method thereof. Background Art

[0002] Surgical sutures are a type of medical device and a widely used biomaterial in the medical and health care process to keep wounds closed and provide necessary support during wound healing. As a medical device implanted in the human body, sutures are in close contact with human tissues during surgical operations. As a foreign body, they may cause certain reactions in the human body and form inflammation at the wound site of the skin or organs after surgery. They also have the possibility of bacterial bioadhesion and are prone to microbial colonization at the wound incision. Therefore, in this case, it is necessary to develop sutures with the function of preventing infection and promoting wound healing to effectively inhibit bacterial reproduction and improve the healing rate.

[0003] Surgical sutures should have good biocompatibility, excellent antibacterial properties, and effective drug carriers to facilitate anti-inflammation and promote wound healing. At present, many studies have used various techniques (such as coating, melt spinning, wet spinning, grafting, electrospinning, air spinning, etc.) to load natural or synthetic antimicrobial agents into suture devices to produce antimicrobial surgical sutures. Although the coating method is simple in process, the poor control of coating thickness and antimicrobial release is a significant disadvantage of the coating process, and the coating is easily detached when distributed on the surface. Melt spinning technology is a technology widely used in the production of commercial sutures. It uses high temperatures to melt polymers, but this high temperature strongly hinders the use of thermosensitive antimicrobial agents in the production process of sutures. Electrospinning can be used to manufacture nanofiber yarns, but the electrospinning process is easily affected by environmental factors (air humidity, temperature, electric field regulation, etc.), has a slow production speed, is difficult to mass produce, and has low fiber strength and is easily deformed or broken during use.

[0004] Ideally, compared with post-treatment methods, the addition of antimicrobial agents during the manufacturing process is more direct and controllable. In recent years, wet spinning has received more attention in the field of manufacturing fiber yarn sutures. The fiber diameter is controllable, the structure and performance are stable, the equipment is simple, the cost is low, and the production efficiency is high. Through wet spinning technology, antimicrobial agents can be introduced into polymer solutions before suture manufacturing to manufacture fiber yarns. Studies have shown that endogenous bioelectric fields are widely present in biological tissues, and endogenous electric fields can have a significant impact on the biological activities and cell behaviors of tissues, organs and cells. In addition, the endogenous bioelectric field at the wound can last for many hours or even days, playing an important regulatory role in the inactivation of bacteria and the migration of cells at the site of injury. Therefore, giving sutures a certain bioelectric field is an effective way to develop antibacterial and healing sutures.

[0005] CN108193342A discloses a method for preparing a drug-loaded nanofiber core-spun yarn for absorbable surgical sutures. The method uses a degradable surgical suture as a core yarn and adopts an electrostatic spinning method to prepare a uniform and continuous drug-loaded nanofiber core-spun yarn.

[0006] CN111790001A discloses a method for producing a three-layer annular absorbable surgical suture for promoting healing and resisting infection. The method uses chitosan fiber as the core, and through a special chemical reaction, a collagen layer is cross-linked on the surface of the chitosan fiber, and then a carboxymethyl chitosan layer is cross-linked outside the collagen layer to produce a three-layer antibacterial and healing-promoting suture.

[0007] The antibacterial and healing-promoting suture prepared by the above method mainly relies on the passive release of antibacterial agents for antibacterial effect, which is uncontrollable.

[0008] The antibacterial coating of existing sutures is mostly distributed on the surface of the material, with poor bonding strength to the material and easy to fall off. The thickness of the antibacterial coating prepared by the coating process is uncontrollable, and it relies on the passive release of the antibacterial coating for antibacterial effect. The antibacterial agent is exposed to the surface, and the antibacterial agent of the suture is released rapidly in the initial stage after implantation. The controllability is poor and the effect is not long-lasting. Melt spinning technology uses high-temperature melting polymers and is not suitable for the use of heat-sensitive antibacterial agents in the production process of sutures. The preparation process of pure nanofiber sutures is relatively complicated, requiring high machine precision, long cycle, and low strength, which cannot meet the requirements of subsequent processing and use. Summary of the invention

[0009] In view of the deficiencies of the above-mentioned prior art, a drug / electric synergistic antibacterial and healing-promoting suture and its preparation method are provided. Through coaxial wet spinning, a fiber with a skin-core structure is constructed, and a micro / nano galvanic couple is constructed between the cortex and the core layer of the fiber. In a humid wound environment, the concentration gradient of the cortex and the core layer is used to play a radial water absorption role (the core layer concentration is greater than the cortex concentration). The positive and negative electrodes of the micro / nano galvanic couple use human tissue exudate as an electrolyte solution to form a closed loop, forming a primary battery, and a discharge reaction occurs. Electrochemical corrosion causes the cortex to appear concave and then form micropores, enhance radial adsorption, promote internal galvanic corrosion and the release of functional drugs in the core layer. The electrochemical reaction of the micro / nano galvanic couple is controlled to produce electrical stimulation, and the controllable release of functional drugs such as antibacterial, anti-inflammatory, and antioxidant drugs loaded on the core layer is achieved by regulating the type of electrode pairs / galvanic couple pairs, the content of electrode pairs / galvanic couple pairs, the size of electrode pairs / galvanic couple particles, and the thickness of the core / skin layer, so as to promote high-quality repair of sutured wounds.

[0010] In order to solve the above technical problems, the technical solution adopted by the present invention is a drug / electric synergistic antibacterial and healing-promoting suture, which is made by twisting fibers with a skin-core structure prepared by coaxial wet spinning, wherein the core layer of the fiber is made of polymer, micro / nano galvanic particles and antibacterial and anti-inflammatory drugs, and the skin layer of the fiber is made of micro / nano galvanic particles with more active electrode positions than the micro / nano galvanic particles of the core layer and polymer, and the galvanic particles formed by the micro / nano galvanic particles on the core layer and the micro / nano galvanic particles on the skin layer utilize human tissue exudate to form a galvanic As the electrolyte solution forms a closed loop, an electrochemical discharge reaction occurs, and electrochemical corrosion causes depressions in the cortex and then forms micropores, thereby achieving controlled release of functional drugs in the core layer; and, in a humid wound environment, the concentration gradient of the cortex and core layer is utilized to achieve radial water absorption and control the electrochemical reaction of the micro / nano galvanic couple; by regulating the type of electrode pairs / galvanic pairs, the content of electrode pairs / galvanic pairs, the size of electrode pairs / galvanic particles, and the thickness of the skin / core layer, the controlled release of antibacterial, anti-inflammatory, and analgesic drugs loaded on the core layer can be achieved, thereby promoting high-quality repair of sutured wounds.

[0011] The above-mentioned drug / electric synergistic antibacterial and healing-promoting suture, the polymers of the cortex and core layer can be sodium alginate, chitosan, cellulose, regenerated cellulose, silk fibroin, polylactic acid (PLA), polycaprolactone (PCL), polylactic acid-polycaprolactone copolymer (PLGA), polysuccinate (PBS).

[0012] In the above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture, the micro / nano galvanic particles can be Ca, Mg, Zn, Fe, Mn, Ag2O, and the particle size is 20-850nm.

[0013] The above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture thread has a diameter of 0.36mm-0.5mm, a diameter of the fiber core layer is 0.12mm-0.21mm; and a thickness of the skin layer is 0.05mm-0.10mm.

[0014] The above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture has an elongation of 14.7%-25% after two yarns are twisted; a tensile strength of 34N-53N; and a friction coefficient of 0.2-0.35.

[0015] The above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture has an antibacterial rate of 96.3%-99.5%

[0016] The above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture thread has a maximum output voltage of 210mV to 340mV.

[0017] The preparation method of the above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture comprises the following steps:

[0018] (1) preparing a core spinning solution: adding 1% to 5% by mass of antibacterial and anti-inflammatory drugs and 1% to 4% by mass of micro / nano galvanic particles to a polymer solution having a mass fraction of 15% to 25%;

[0019] (2) preparing the skin spinning solution: adding micro / nano galvanic particles having different electrode positions from the core layer micro / nano galvanic particles to a polymer solution having a mass fraction of 3% to 6%, accounting for 2% to 5% of the solute mass fraction;

[0020] (3) Stir the solution obtained in the above steps (1) and (2) for 8-12 hours at room temperature and sonicate for 2 hours to ensure that the micro / nano galvanic particles are evenly dispersed; filter and degas the mixed solution for 30 minutes;

[0021] (4) Setting the parameters of the spinning equipment: according to the above-mentioned polymer spinning solutions, the nozzle temperature range is 30-65°C; the relative humidity (RH) range is 30%-60%; the injection speed range of the core layer spinning solution and the skin layer spinning solution is 0.5-3mL / min;

[0022] (5) The core layer spinning solution and the skin layer spinning solution are ejected simultaneously through a common spinning orifice and form a coaxial structure during the spinning process; the core layer material is wrapped in the skin layer material to form a fiber with a skin-core structure;

[0023] (6) The formed skin-core structure fiber enters the coagulation bath;

[0024] (7) drawing through a godet at a rate of 100-200 rpm, with a drawing displacement change of 10-20%, and finally collecting the sheath-core fiber by a winding device; the collected sheath-core fiber is washed with water to remove the attached coagulation bath and solvent;

[0025] (8) Send the core-sheath fiber to the stretching-twisting machine for post-processing. According to the actual needs of the suture, the two fibers are stretched and rotated into a single yarn with uniform thickness, or two or more single yarns are twisted to form a multi-strand yarn; twist: 150-300 turns / m; temperature: 20-40°C; humidity: 40%-60%;

[0026] (9) The obtained single yarn or multi-ply yarn is placed in a setting box for heating and twisting, and the twisting temperature is 40-60°C.

[0027] In the method for preparing the above-mentioned drug / electricity synergistic antibacterial and healing-promoting suture, when the polymer solution in step (1) or step (2) is a sodium polyalginate solution, the coagulation bath in step (6) is 4-7wt% CaCl2.

[0028] The beneficial effects of the drug / electricity synergistic antibacterial and healing-promoting suture thread and the preparation method thereof of the present invention are:

[0029] (1) The present invention prepares a sheath-core structure fiber by adding micro / nano galvanic particles with different electrode potentials to a sheath-core polymer spinning solution, and further spinning and twisting the sheath-core structure fiber into a suture. The micro / nano galvanic particles can undergo an electrochemical reaction in a wound or tissue exudate environment, wherein the sheath galvanic particles (negative electrode) lose electrons and the core galvanic particles (positive electrode) gain electrons, thereby continuously generating electrical stimulation. With the loss of the core or sheath micro / nano galvanic particles, a multi-level micro / nano pore structure is formed on the surface or inside of the fiber. By regulating the type of electrode galvanic particles, the content of electrode galvanic particles, the size of electrode galvanic particles and the thickness of the sheath / core layer, the core layer is loaded with antibacterial, anti-inflammatory, antioxidant and other drugs, and the high-quality repair of sutured tissue is promoted through continuous electrical stimulation and the synergistic antibacterial, anti-inflammatory, antioxidant and healing effects of the controlled release of drugs.

[0030] (2) By regulating the type of electrode couples, the content of electrode couples, the thickness of the skin / core layer, and the degree of twist, the intensity, distribution, and duration of electrical stimulation can be regulated to match the healing cycle of the sutured tissue.

[0031] (3) The preparation process of the method of the present invention is simple, easy to promote, and has broad social benefits and economic value. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 Cell migration statistics. DETAILED DESCRIPTION

[0033] The present invention is described in detail below with reference to specific embodiments.

[0034] A drug / electricity synergistic antibacterial and healing-promoting suture is formed by twisting fibers with a skin-core structure prepared by coaxial wet spinning, wherein the core layer of the fiber is prepared by a polymer, micro / nano galvanic particles and antibacterial and anti-inflammatory drugs, and the skin layer of the fiber is prepared by micro / nano galvanic particles with different electrode positions from the micro / nano galvanic particles on the core layer and a polymer, and the galvanic particles formed by the micro / nano galvanic particles on the core layer and the micro / nano galvanic particles on the skin layer use human tissue exudate as an electrolyte solution to form a closed loop to form a primary electrode. The cell generates a discharge reaction, and electrochemical corrosion causes the shell layer to dent and form micropores, thereby realizing the controlled release of the functional drugs in the core layer; and, in a slightly moist wound environment, the concentration gradient of the cortex and core layer is utilized to achieve radial water absorption, control the release of micro / nano galvanic particles, and spontaneously and continuously generate electrical stimulation; by regulating the type of electrode pairs / galvanic pairs, the content of electrode pairs / galvanic pairs, the size of electrode pairs / galvanic particles, and the thickness of the core / shell layer, the controlled release of the antibacterial, anti-inflammatory, and analgesic drugs loaded on the core layer is achieved, promoting high-quality repair of sutured wounds.

[0035] Example 1

[0036] The preparation method of drug / electricity synergistic antibacterial and healing-promoting suture thread comprises the following steps:

[0037] (1) preparing a core spinning solution: adding 1% by mass of curcumin and 2% by mass of nano-Ag2O particles accounting for 2% by mass of the solute PBS to a 20% by mass polysuccinate (PBS) solution, wherein the particle size of the nano-Ag2O particles is 250 nm;

[0038] (2) Preparation of cortex spinning solution: In a sodium alginate solution with a mass fraction of 5%, nano Zn particles with a mass fraction of 4% of the solute sodium alginate are added to the cortex (negative electrode), wherein the particle size of the nano Zn particles is 250 nm;

[0039] (3) At room temperature, the solution obtained in the above steps (1) and (2) was magnetically stirred at 60° C. for 8 hours and ultrasonicated for 2 hours to ensure that the micro / nano galvanic particles were evenly dispersed; the mixed solution was filtered and degassed for 30 minutes;

[0040] (4) Setting the spinning equipment parameters: nozzle temperature 45°C, humidity 30%; injection speed of core layer spinning solution and skin layer spinning solution: 0.5 mL / min each;

[0041] (5) The core layer spinning solution and the skin layer spinning solution are ejected simultaneously through a common spinning orifice and form a coaxial structure during the spinning process; the core layer material is wrapped in the skin layer material to form a fiber with a skin-core structure;

[0042] (6) The formed skin-core fiber enters a coagulation bath containing 4 wt% CaCl2. 2 +) will undergo ion exchange reaction with anions in the fiber. This ion exchange helps to enhance the stability of the fiber and promote the fiber to form a gel structure;

[0043] (7) drawing through a godet at a rate of 160 rpm and a drawing rate (percentage of length change during the drawing process) of 15%, and finally collecting the sheath-core fibers by a winding device; the collected sheath-core fibers are washed with water to remove the attached coagulation bath and solvent;

[0044] (8) The core-sheath fiber is sent to a stretching-twisting machine for post-treatment, and then two or more fibers are stretched and twisted into a continuous single yarn or multi-strand yarn through a series of temperature (20°C) and humidity (40%) control parameters, with a twist degree of 150 turns / m;

[0045] (9) By twisting the two yarns, the final drug / electric synergistic antibacterial and healing-promoting suture thread is obtained.

[0046] Taking Ag2O / Zn battery as an example, the reaction equation is as follows:

[0047] Anode (Zn electrode): Zn+2OH - -2e - →Zn(OH)2

[0048] Cathode (Ag2O electrode): Ag2O+H2O+2e - →2Ag+2OH -

[0049] In this embodiment, the diameter of the core layer of the obtained electroactive antibacterial and healing-promoting yarn is 0.12 mm, and the thickness of the yarn skin layer is 0.08 mm.

[0050] The diameter of the drug / electricity synergistic antibacterial and healing-promoting suture thread is 0.36 mm-0.4 mm.

[0051] The elongation is 20%; the tensile strength is 43N; the friction coefficient is 0.2.

[0052] The antibacterial rate of E.coli is 96.7%. The antibacterial rate of S.aureus is 98.4%. The antibacterial rate after 24 hours is 85.0%.

[0053] The duration of electrical stimulation was 78h; the average drug release rate was 17±2μg / h.

[0054] Example 2

[0055] The similarities between this embodiment and embodiment 1 are not repeated here, and the difference lies in that:

[0056] (1) preparing a core spinning solution: adding 5% by mass of chlorhexidine and 1% by mass of nano-Pt particles accounting for 1% by mass of the solute PLA to a polylactic acid (PLA) solution having a mass fraction of 25%, wherein the nano-Pt particles have a particle size of 20 nm;

[0057] (2) Preparation of cortex spinning solution: Adding nano-Mg particles with a mass fraction of 2% of the sodium alginate solute to the cortex (negative electrode), wherein the particle size of the nano-Mg particles is 20 nm;

[0058] (3) At room temperature, the solution obtained in the above steps (1) and (2) was magnetically stirred at 60° C. for 10 hours and ultrasonicated for 2 hours to ensure that the micro / nano galvanic particles were evenly dispersed; the mixed solution was filtered and degassed for 30 minutes;

[0059] (4) Setting the spinning equipment parameters: nozzle temperature 65°C, humidity 60%; injection speed of core layer spinning solution and skin layer spinning solution: 1.5 mL / min each;

[0060] (5) The core layer spinning solution and the skin layer spinning solution are ejected simultaneously through a common spinning orifice and form a coaxial structure during the spinning process; the core layer material is wrapped in the skin layer material to form a fiber with a skin-core structure;

[0061] (6) The formed skin-core fiber enters a coagulation bath, wherein the coagulation bath is 7 wt % CaCl2. The calcium ions (Ca 2 +) will undergo ion exchange reaction with anions in the fiber. This ion exchange helps to enhance the stability of the fiber and promote the fiber to form a gel structure;

[0062] (7) drawing through a godet at a rate of 200 rpm and a drawing rate (percentage of length change during the drawing process) of 20%, and finally collecting the sheath-core fibers by a winding device; the collected sheath-core fibers are washed with water to remove the attached coagulation bath and solvent;

[0063] (8) The core-sheath fiber is sent to a stretching-twisting mechanism for post-processing, and then two or more fibers are stretched and rotated into a continuous single yarn or multi-strand yarn through a series of temperature (30°C) and humidity (50%) control parameters, with a twist degree of 200 turns / m.

[0064] (9) By twisting the two yarns, the final drug / electric synergistic antibacterial and healing-promoting suture thread is obtained.

[0065] Principle of spontaneous generation and electrochemical corrosion: For Mg-Pt primary cells, once the metal electrodes are placed in the human body fluid environment, a spontaneous redox reaction will occur.

[0066] Anode (Mg electrode): Mg-2e - →Mg 2+

[0067] Cathode (Pt electrode): 2H2O+2e - →2OH - +H2↑

[0068] These reactions not only produce electrical stimulation, but also lead to electrochemical corrosion of the shell material, forming a microporous structure, which allows the core layer drug to be gradually released.

[0069] In addition to electrochemical stimulation, these reactions can also generate hydrogen gas. Low concentrations of H2 have been found to modulate inflammation, while high concentrations of H2 inhibit mitochondrial respiration and disrupt redox homeostasis, thereby causing cancer cell apoptosis and damage.

[0070] In this embodiment, the diameter of the core layer of the obtained electroactive antibacterial and healing-promoting yarn is 0.21 mm, and the thickness of the yarn skin layer is 0.10 mm.

[0071] The diameter of the drug / electricity synergistic antibacterial and healing-promoting suture thread is 0.42 mm-0.5 mm.

[0072] Elongation: about 14.7%. Tensile strength: about 34N. Friction coefficient: about 0.25. E.coli antibacterial rate: 98%. S.aureus antibacterial rate: 96.3%. Electrical stimulation duration: about 65 hours.

[0073] Average drug release rate: 15±1.5μg / h.

[0074] Example 3

[0075] The similarities between this embodiment and embodiment 1 are not repeated here, and the difference lies in that:

[0076] (1) preparing a core spinning solution: adding 5% by mass of heparin and 4% by mass of nano-Fe-Mn particles accounting for 4% by mass of the solute PCL to a polycaprolactone (PCL) solution having a mass fraction of 15%, wherein the particle size of the nano-Fe-Mn particles is 850 nm;

[0077] (2) Preparation of cortex spinning solution: The cortex (negative electrode) is prepared by adding 5% by mass of nano-Mg particles to a 3% by mass sodium alginate solution, wherein the nano-Mg particles have a particle size of 850 nm.

[0078] (3) At room temperature, the solution obtained in the above steps (1) and (2) was magnetically stirred at 60° C. for 12 hours and ultrasonicated for 2 hours to ensure that the nano-metal particles were evenly dispersed; the mixed solution was filtered and degassed for 30 minutes;

[0079] (4) Set the spinning equipment parameters: nozzle temperature 30°C, humidity 50%; injection speed of core layer spinning solution and skin layer spinning solution: 3 mL / min each;

[0080] (5) The core layer spinning solution and the skin layer spinning solution are ejected simultaneously through a common spinning orifice and form a coaxial structure during the spinning process; the core layer material is wrapped in the skin layer material to form a fiber with a skin-core structure;

[0081] (6) The formed skin-core fiber enters a coagulation bath, wherein the coagulation bath is 5 wt% CaCl2. The calcium ions (Ca 2 +) will undergo ion exchange reaction with anions in the fiber. This ion exchange helps to enhance the stability of the fiber and promote the fiber to form a gel structure;

[0082] (7) drawing through a godet at a rate of 100 rpm and a drawing rate (percentage of length change during the drawing process) of 10%, and finally collecting the sheath-core fibers by a winding device; the collected sheath-core fibers are washed with water to remove the attached coagulation bath and solvent;

[0083] (8) The core-sheath fiber is sent to a stretching-twisting mechanism for post-processing, and then two or more fibers are stretched and rotated into a continuous single yarn or multi-strand yarn through a series of temperature (40°C) and humidity (60%) control parameters, with a twist degree of 300 turns / m.

[0084] (9) By twisting the two yarns, the final drug / electric synergistic antibacterial and healing-promoting suture thread is obtained.

[0085] Mg and Fe-Mn are used as anode and cathode, respectively, because they have suitable electrochemical potential, ideal biocompatibility, and ideal degradation rate in biological environment. As an essential trace element in human body, magnesium has been used as stimulation electrode in neural interface for nerve regeneration, showing minimal toxicity, and Fe and Mn are considered as biocompatible materials for cardiovascular stents.

[0086] Self-generation principle and electrochemical corrosion:

[0087] Anode reaction is mainly metal dissolution: Mg-2e - →Mg 2+

[0088] The cathode reaction involves the reduction of dissolved oxygen: 2O + 4e - →4OH- Or hydrogen evolution: 2H+2e + →H2↑

[0089] In this embodiment, in this embodiment, the diameter of the positive electrode core layer of the obtained electroactive antibacterial and healing-promoting yarn is 0.2 mm, and the thickness of the negative electrode skin layer of the yarn is 0.05 mm.

[0090] The diameter of the drug / electricity synergistic antibacterial and healing-promoting suture thread is 0.38 mm to 0.46 mm.

[0091] Elongation: about 25%. Tensile strength: about 53N. Friction coefficient: about 0.35. E.coli antibacterial rate: 99%. S.aureus antibacterial rate: 99.5%. Duration of electrical stimulation: 105 hours. Average drug release rate: 26±2μg / h.

[0092] In order to better evaluate the various effects of the present invention in the wound suture microenvironment, the following table is provided:

[0093] 1. Characterization of electroactivity

[0094] Evaluation method of electroactive effect: The suture was immersed in PBS buffer to fully wet it, and then the voltage change and electrical stimulation duration of the suture under tensile simulation conditions (speed 1-20 mm / s, stretching range: 0-180 mm, bending range: 0-180°, bending speed: 10-30° / s) were measured using an FT2000 flexible electronic tester.

[0095] Measured maximum open circuit voltage Duration of electrical stimulation Nylon suture 0mV / s 0 Polypropylene suture 0mV / s 0 Cotton suture thread 0mV / s 0 Example 1 ~210mV / s ~78h Example 2 ~340mV / s ~65h Example 3 ~310mV / s ~105h

[0096] As can be seen from the above table, the voltage cannot be measured for nylon sutures, polypropylene sutures and cotton sutures. This is because these three sutures lack special materials and structural designs that respond to electrical stimulation and cannot provide effective electrical stimulation for the healing of sutured wounds. Compared with nylon sutures, polypropylene sutures and cotton sutures, the sutures prepared in Examples 1, 2, and 3 can measure voltage. This is because the micro / nano galvanic particles with different electrode potentials in the skin / layer structure of the sutures prepared in Examples 1, 2, and 3 can be activated by human tissue exudate, produce electrochemical reactions, and provide electrical stimulation. In addition, the electrochemical corrosion of the micro / nano galvanic particles forms micropores in the cortex, enhances radial water absorption, and promotes the body fluid to further reach the core layer, so that the electrochemical reaction continues and produces continuous electrical stimulation. In Example 1, the standard potential difference of the Ag / Zn primary battery is the smallest, so the highest open circuit voltage measured is also the smallest. In Example 2, although the low concentration of 1% positive electrode Pt can inhibit the corrosion of the suture in the body and increase the electrical stimulation time, it is not a major factor due to its low concentration. According to the concentration ratio, Mg only accounts for 0.12% (6% × 2%) of the total mass of the negative electrode spinning solution, which is the least content compared to Examples 1 and 3. The cortex will be consumed relatively quickly, so the electrical stimulation time is the shortest. Because its Pt / Mg potential difference is the largest, the measured voltage value is the highest. Compared with Examples 1 and 2, the suture prepared in Example 3 has the longest electrical stimulation time. This is because the content of Mg-FeMn galvanic particles is high, and the oxidation reaction of Mg is relatively slow, the conductivity is relatively low compared to Ag and Zn, and the duration of the electrochemical reaction is long, so that a longer electrical stimulation time can be provided.

[0097] 2. Characterization of drug sustained release effect

[0098] In vitro drug release experiment: The suture samples were immersed in simulated body fluids, and samples were taken regularly. The concentration of the released drug in the solution was measured using ultraviolet-visible spectroscopy (UV-Vis), and the drug release rate was calculated based on the change in drug concentration.

[0099] Average drug release rate Duration of drug release Nylon suture 0 0 Polypropylene suture 0 0 Cotton suture thread 0 0 Example 1 17 ± 2 μg / h 70±1h Example 2 15 ± 1.5 μg / h 92±3h Example 3 26±2μg / h 86±2.5h

[0100] As can be seen from the above table, nylon sutures, polypropylene sutures and cotton sutures did not show drug sustained release ability under given conditions, because they did not load functional drugs. The sutures prepared in Examples 1, 2, and 3 showed different drug release characteristics, and multiple factors such as the rate of micropore formation by electrochemical corrosion, micropore diameter, drug properties, fiber crosslinking degree, and suture diameter will affect the drug sustained release effect. Compared with Examples 1 and 2, the average drug release rate of the suture in Example 3 is higher. This is because compared with Examples 1 and 2, the content of Fe-Mn / Mg galvanic nanoparticles in Example 3 is higher and the particle size is the largest (850nm), and a large number of pore structures can be formed after the reaction to promote drug release. Compared with Examples 1 and 3, the drug release duration of the suture prepared in Example 2 is the longest. This is because the spinning solution concentration and coagulation bath concentration used for the cortex in Example 2 are higher, resulting in a denser structure of the cortex and a higher concentration of the drug contained therein. At the same time, the particle size of the Mg electrode particles used is relatively small (20 nm), and the micropores formed after the electrochemical reaction are smaller, which slows down the diffusion release of the drug.

[0101] 3. Characterization of antibacterial properties

[0102] Antibacterial test process: Escherichia coli and Staphylococcus aureus were selected as test strains (GB / T20944.1-2007). Antibacterial activity was measured using the plate colony counting method. The sample was placed in a sterile centrifuge tube containing 5 mL of PBS solution and shaken thoroughly. Then, 300 μL of bacterial solution was transferred and added to a nutrient agar culture dish and cultured in a 37°C constant temperature incubator for 18-24 hours. Finally, a photo was taken and the colony count was counted using PS software, and the inhibition rate was calculated. The antibacterial properties are shown in the following table:

[0103] E.coli antibacterial rate S. aureus antibacterial rate Nylon suture 21.6% 16.5% Polypropylene suture 34.4% 27.9% Cotton suture thread 3.6% 2.8% Example 1 96.7% 98.4% Example 2 98% 96.3% Example 3 99% 99.5%

[0104] It can be seen from the above table that the antibacterial rates of nylon sutures, polypropylene sutures and cotton sutures against E. coli and S. aureus are very low, and the antibacterial properties are poor. Among them, the antibacterial properties of polypropylene sutures are slightly better among the three. This is because the chemical structure of polypropylene only contains carbon-carbon bonds and hydrogen atoms, no other functional groups, is hydrophobic, and bacteria are not easy to adhere and grow. Compared with nylon sutures, polypropylene sutures and cotton sutures, the sutures prepared in Examples 1, 2, and 3 of the present invention can be activated by tissue exudate, electrochemical discharge reactions occur, electrical stimulation is generated, and metal ions are released. At the same time, the drugs in the core layer fibers are slowly released through the micropores formed by the electrochemical reaction, and have a drug / electric synergistic antibacterial effect, giving them excellent antibacterial properties. Compared with Example 1 and Example 2, the drug concentration and the content of micro / nano galvanic particles in Example 3 are both higher, and the particle size of the micro / nano galvanic particles is the largest, which is 850nm. Therefore, the average drug release rate is high and the electrical stimulation lasts for a long time, resulting in an excellent drug / electric synergistic antibacterial effect.

[0105] 4. Mechanical properties characterization

[0106] Mechanical properties test: This test is based on the standard YY / T 1832-2022 Sports Medicine Implant Suture Tensile Test Method. The sample is clamped at both ends of the fixture of the Instron material testing machine. The tensile speed is 300mm / min, the clamping length is set to 125mm, the test environment temperature is 22±2℃, the relative humidity is 65±2℃, and each sample is tested 10 times to take the average value.

[0107] Maximum tensile load Elastic modulus Nylon suture 55±3N 3±1Gpa Polypropylene suture 37±5N 2±0.5GPa Cotton suture thread 24±10N 5±1.5GPa Invention Example 1 38±2N 1.6±0.5GPa Invention Example 2 49±4N 2.5±0.2GPa Invention Example 3 36±2N 1.2±0.2GPa

[0108] As can be seen from the above table, nylon sutures, polypropylene sutures and cotton sutures have certain tensile strength and flexibility, and can withstand the tension generated by wounds in daily activities. Compared with the above three sutures, the sutures prepared in Examples 1, 2, and 3 of the invention also show good tensile strength as a whole, thanks to the skin-core structure design that optimizes stress distribution, improves overall mechanical strength, and can provide sufficient stress support for wound healing. In addition, compared with nylon sutures, polypropylene sutures and cotton sutures, the elastic modulus of the sutures prepared in Examples 1, 2, and 3 is lower, indicating that it is softer, easier to operate, and can adapt to irregularly shaped wounds. Compared with Examples 1 and 3, Example 2 shows higher tensile strength, which is due to the core layer of Example 2 being a higher concentration of PLA, which can provide strong mechanical support and tensile strength. In addition, the higher strength of PLA and the filling and reinforcing effect of Cu and Ti galvanic particles give the suture of Example 2 a higher elastic modulus. PBS is an aliphatic polyester with high crystallinity and strong intermolecular forces, while PCL is a linear polyester with a long molecular chain and high flexibility, low crystallinity, and weak intermolecular forces, so the elastic modulus of Example 1 is higher than that of Example 3.

[0109] 5. Biocompatibility characterization

[0110] Cytotoxicity test: Human embryonic lung fibroblasts (HELF) were used as experimental cells to evaluate in vitro cytotoxicity by 3-(4,5-dimethylthiazol-2-yl), 2-5-diphenyltetrazolium bromide (MTT) assay. The samples were first sterilized and then soaked in a sterile environment for 24 hours to obtain 100% sample extracts. Then, the cells were incubated with the sample extracts in an incubator for 48 hours. Finally, the effect of the material on the cells was evaluated by measuring the cell survival rate.

[0111] Hemolysis rate determination: 1. Prepare red blood cell suspension, collect blood from healthy rabbits, and treat it with anticoagulant heparin. Centrifuge the blood sample at 1500rpm for 10 minutes to separate the red blood cells, remove the supernatant (plasma and white blood cells), wash the red blood cells with normal saline 3 times, remove the supernatant each time, and adjust the concentration to 2% red blood cell suspension. 2. Cut the suture sample to be tested into a length of 1cm, place it in a test tube, and add 10ml of red blood cell suspension. 3. Set up a control group, negative control: only add red blood cell suspension and normal saline (no material), negative control: add red blood cell suspension and distilled water (no material). 4. Incubate all test tubes in a 37℃ water bath for 1h, centrifuge (1500rpm, 10 minutes), and separate the supernatant. 5. Measure absorbance: Use a spectrophotometer to measure the absorbance (OD value) of the supernatant of each test tube at a wavelength of 540nm. 6. Calculate the hemolysis rate, hemolysis rate = (sample OD value - negative control OD value) / (positive control OD value - negative control OD value) × 100%.

[0112] Cell viability Red blood cell lysis rate Nylon suture ~87.7% ~4.1% Polypropylene suture ~95.0% ~2.7% Cotton suture thread ~84.3% ~5.0% Example 1 ~91% ~3.5% Example 2 ~94.7% ~2.3% Example 3 ~88% ~4.9%

[0113] As can be seen from the above table, the cell survival rates of nylon sutures, polypropylene sutures and cotton sutures are all greater than 85%, and the hemolysis rates are all lower than 5%, showing good biocompatibility. The cell survival rates of the sutures prepared in Examples 1, 2, and 3 are all greater than 88%, and the hemolysis rates are all lower than 4.5%, showing excellent biocompatibility, mainly due to the fact that the main part of the sutures uses sodium alginate, which is usually extracted from seaweed and is a natural high-molecular polysaccharide compound that is similar to many components in organisms, and therefore has good biocompatibility. It can be degraded in the body by certain biological enzymes (such as alginate) to produce non-toxic metabolites, which reduces its long-term irritation and damage to tissues. Sodium alginate has good adhesion and affinity, can bind to the wound surface and cells, promote wound healing, and reduce inflammatory responses. Considering that high concentration of galvanic particles will accelerate the electrochemical corrosion, and high concentration of galvanic particles will generate too much reactive oxygen species (ROS), causing oxidative stress, leading to cell damage or death, compared with Examples 1 and 3, the total content of galvanic particles added in Example 2 is the least, so the cell survival rate of Example 2 is the highest. The total content of Fe-Mn / Mg galvanic particles in Example 3 is the highest, and the high concentration of galvanic particles interacts with the red blood cell membrane, destroying its integrity, causing red blood cell lysis, releasing hemoglobin, and increasing the hemolysis rate, so compared with Examples 1 and 2, Example 3 has the highest red blood cell lysis rate, up to 11.9%.

[0114] 6. Transwell test

[0115] Cut the suture sample into small pieces and process it into a shape suitable for placement in the Transwell insert. Select HELF cells for culture, plant the cells in the upper chamber of the Transwell insert, and place the processed suture sample in the upper chamber of the Transwell insert for co-culture with the cells. Add appropriate culture medium (chemical inducers can be added to promote cell migration, such as serum, etc.) to the lower chamber of the Transwell insert, place the Transwell insert in an incubator for 24 hours and 48 hours, use fluorescent staining to stain the cells that migrate to the membrane holes of the lower chamber, observe with a microscope, take pictures and record, and count the number of cells that migrate to the lower chamber.

[0116] Figure 1 is a bar graph of three parallel experiments. Figure 1 It can be seen that the sutures prepared in Examples 1, 2, and 3 have a higher cell migration rate compared with nylon sutures, polypropylene sutures, and cotton sutures. This is because the micro / nano galvanic particles contained in the skin-core layer in Examples 1, 2, and 3 can generate electrical stimulation after being activated by wound exudate, and the electrical stimulation has the function of guiding cell migration and proliferation, thereby promoting wound healing. Compared with Examples 1 and 3, Example 2 has the largest number of cell migrations. This is because the Ag / Zn galvanic couple used in Example 1 can generate electrical stimulation that matches the cell response after being activated, and the Pt / Mg galvanic couple content is moderate, which guides the cells to migrate in the direction of the electric field, which can enhance the migration speed of epithelial cells and accelerate the epithelialization process, thereby accelerating the closure of epidermal wounds. In Example 1, since the Ag / Zn potential difference is the lowest and the electrical stimulation generated is the smallest, the ability to guide cell migration is the weakest. In Example 3, the electrical stimulation intensity is weak, and the galvanic particle content is too high compared with that in Examples 1 and 2, which results in increased cytotoxicity, cell membrane damage, and hindered cytoskeleton reorganization, which have a significant negative impact on cell migration and are also lower than in Example 2.

[0117] Of course, the above description is not a limitation of the present invention, and the present invention is not limited to the above examples. Changes, modifications, additions or substitutions made by ordinary technicians in this technical field within the essential scope of the present invention should also fall within the protection scope of the present invention.

Claims

1. A drug / electricity synergistic antibacterial and healing-promoting suture, characterized in that: The invention is obtained by twisting a fiber having a core-skin structure prepared by coaxial wet spinning, wherein the core layer of the fiber is prepared by polymer, micro / nano galvanic particles and antibacterial and anti-inflammatory drugs, and the cortex of the fiber is prepared by micro / nano galvanic particles and polymer having more active electrode positions than the micro / nano galvanic particles of the core layer. The galvanic particles formed by the micro / nano galvanic particles on the core layer and the micro / nano galvanic particles on the cortex use human tissue exudate as an electrolyte solution to form a closed loop, and an electrochemical discharge reaction occurs. Electrochemical corrosion causes depressions in the cortex and forms micropores, thereby realizing the controlled release of the functional drugs in the core layer; and, in a humid wound environment, the concentration gradient of the cortex and the core layer is used to play a radial water absorption role to control the electrochemical reaction of the micro / nano galvanic couple; and the controlled release of the antibacterial, anti-inflammatory and analgesic drugs loaded on the core layer is achieved by regulating the type of electrode pairs / galvanic pairs, the content of electrode pairs / galvanic pairs, the size of electrode pairs / galvanic particles and the thickness of the cortex / core layer, thereby promoting the high-quality repair of sutured wounds.

2. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 1 is characterized in that: The polymers of the skin layer and the core layer can be sodium alginate, chitosan, cellulose, regenerated cellulose, silk fibroin, polylactic acid (PLA), polycaprolactone (PCL), polylactic acid-polycaprolactone copolymer (PLGA), polysuccinate (PBS).

3. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 2 is characterized in that: The micro / nano galvanic particles can be Ca, Mg, Zn, Fe, Mn, Ag2O, and the particle size is 20-850nm.

4. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 3 is characterized in that: The diameter of the drug / electricity synergistic antibacterial and healing-promoting suture thread is 0.36mm-0.5mm, the diameter of the fiber core layer is 0.12mm-0.21mm; and the thickness of the skin layer is 0.05mm-0.10mm.

5. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 4 is characterized in that: The elongation of the suture thread after two yarns are twisted is 14.7%-25%; the tensile strength is 34N-53N; and the friction coefficient is 0.2-0.

35.

6. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 5 is characterized in that: The antibacterial rate is 96.3%-99.5%.

7. The drug / electricity synergistic antibacterial and healing-promoting suture according to claim 6 is characterized in that: Maximum output voltage 210mV~340mV.

8. The drug / electricity synergistic antibacterial and healing-promoting suture according to any one of claims 1 to 7, characterized in that: The following steps are involved: (1) preparing a core spinning solution: adding 1% to 5% by mass of antibacterial and anti-inflammatory drugs and 1% to 4% by mass of micro / nano galvanic particles to a polymer solution having a mass fraction of 15% to 25%; (2) preparing the skin spinning solution: adding micro / nano galvanic particles having different electrode positions from the core layer micro / nano galvanic particles to a polymer solution having a mass fraction of 3% to 6%, accounting for 2% to 5% of the solute mass fraction; (3) Stir the solution obtained in the above steps (1) and (2) for 8-12 hours at room temperature and sonicate for 2 hours to ensure that the micro / nano galvanic particles are evenly dispersed; filter and degas the mixed solution for 30 minutes; (4) Setting the parameters of the spinning equipment: according to the above-mentioned polymer spinning solutions, the nozzle temperature range is 30-65°C; the relative humidity (RH) range is 30%-60%; the injection speed range of the core layer spinning solution and the skin layer spinning solution is 0.5-3mL / min; (5) The core layer spinning solution and the skin layer spinning solution are ejected simultaneously through a common spinning orifice and form a coaxial structure during the spinning process; the core layer material is wrapped in the skin layer material to form a fiber with a skin-core structure; (6) The formed skin-core structure fiber enters the coagulation bath; (7) drawing through a godet at a rate of 100-200 rpm, with a drawing displacement change of 10-20%, and finally collecting the sheath-core fiber by a winding device; the collected sheath-core fiber is washed with water to remove the attached coagulation bath and solvent; (8) Send the core-sheath fiber to the stretching-twisting machine for post-processing. According to the actual needs of the suture, the two fibers are stretched and rotated into a single yarn with uniform thickness, or two or more single yarns are twisted to form a multi-strand yarn; twist: 150-300 turns / m; Temperature: 20-40℃; Humidity: 40%-60%; (9) The obtained single yarn or multi-ply yarn is placed in a setting box for heating and twisting, and the twisting temperature is 40-60°C.

9. The method for preparing the drug / electricity synergistic antibacterial and healing-promoting suture according to claim 8, characterized in that: When the polymer solution in step (1) or step (2) is a sodium polyalginate solution, the coagulation bath in step (6) is 4-7 wt % CaCl2.

Citation Information

Patent Citations

  • Preparing method of medicine-carrying nanofiber core spun yarn for absorbable surgical suture

    CN108193342A

  • Manufacturing method of absorbable surgical suture with three-layer annular structure for promoting healing and resisting infection

    CN111790001A

Cited By

  • Radio stimulation surgical suture for promoting peripheral nerve healing and preparation method and application thereof

    CN120078926A

  • Composite medical suture and preparation method thereof

    CN120514905A

  • Composite medical suture and preparation method thereof

    CN120514905B

  • Magnetic field-induced absorbable surgical suture of core-sheath type and method for its production

    CN122827740A